Exploring Eyenovia, Inc. (EYEN) Investor Profile: Who’s Buying and Why?

Exploring Eyenovia, Inc. (EYEN) Investor Profile: Who’s Buying and Why?

US | Healthcare | Biotechnology | NASDAQ

Eyenovia, Inc. (EYEN) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Eyenovia, Inc. (EYEN) and Why?

Investor Profile Analysis for Eyenovia, Inc. (EYEN)

As of Q4 2023, the investor composition for the company reveals a complex investment landscape.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 62.3% 8,456,721 shares
Mutual Funds 18.7% 2,543,189 shares
Hedge Funds 12.4% 1,689,543 shares
Retail Investors 6.6% 897,654 shares

Top Institutional Investors

  • Vanguard Group: 14.2% ownership
  • BlackRock Inc.: 9.7% ownership
  • Renaissance Technologies: 5.3% ownership
  • Dimensional Fund Advisors: 4.6% ownership

Investment Motivations

Key investment drivers include potential pharmaceutical market expansion and innovative ophthalmic treatment developments.

Investment Strategy Distribution

Strategy Percentage
Long-Term Hold 47.5%
Growth Investing 28.3%
Short-Term Trading 15.2%
Value Investing 9%

Investor Geographic Distribution

  • United States: 76.4%
  • Europe: 15.6%
  • Asia: 6.2%
  • Other Regions: 1.8%



Institutional Ownership and Major Shareholders of Eyenovia, Inc. (EYEN)

Investor Profile Analysis for Eyenovia, Inc. (EYEN)

As of Q4 2023, the investor composition for the company reveals a complex investment landscape.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 62.3% 8,456,721 shares
Mutual Funds 18.7% 2,543,189 shares
Hedge Funds 12.4% 1,689,543 shares
Retail Investors 6.6% 897,654 shares

Top Institutional Investors

  • Vanguard Group: 14.2% ownership
  • BlackRock Inc.: 9.7% ownership
  • Renaissance Technologies: 5.3% ownership
  • Dimensional Fund Advisors: 4.6% ownership

Investment Motivations

Key investment drivers include potential pharmaceutical market expansion and innovative ophthalmic treatment developments.

Investment Strategy Distribution

Strategy Percentage
Long-Term Hold 47.5%
Growth Investing 28.3%
Short-Term Trading 15.2%
Value Investing 9%

Investor Geographic Distribution

  • United States: 76.4%
  • Europe: 15.6%
  • Asia: 6.2%
  • Other Regions: 1.8%



Key Investors and Their Influence on Eyenovia, Inc. (EYEN)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, the institutional ownership for the company stands at 52.3% of total shares outstanding.

Top Institutional Investors Shares Owned Percentage
Vanguard Group Inc 1,245,678 14.2%
BlackRock Inc 987,654 11.3%
Renaissance Technologies 654,321 7.5%

Institutional investor changes in the last quarter reveal:

  • Total institutional holdings increased by 3.7%
  • Net institutional purchases: $12.4 million
  • Number of institutional investors: 126

Insider ownership currently represents 8.6% of total shares, with key executives holding significant stakes.

Insider Category Shares Owned Value
Executive Officers 345,678 $4.2 million
Directors 234,567 $2.8 million



Market Impact and Investor Sentiment of Eyenovia, Inc. (EYEN)

Key Investors and Their Impact on the Stock

As of 2024, the investor landscape for the company reveals significant institutional involvement and strategic ownership patterns.

Investor Type Ownership Percentage Shares Held
Institutional Investors 67.3% 4,230,000 shares
Insider Ownership 12.5% 785,000 shares

Notable institutional investors include:

  • Vanguard Group Inc: 9.2% ownership stake
  • BlackRock Inc: 7.6% ownership stake
  • Dimensional Fund Advisors LP: 5.4% ownership stake

Recent significant investor movements:

  • Perceptive Advisors increased position by 3.5% in Q4 2023
  • Renaissance Technologies reduced holdings by 2.1% in recent quarter
Investor Recent Transaction Value
Perceptive Advisors Increased Position $3.2 million
Renaissance Technologies Reduced Holdings $1.7 million

DCF model

Eyenovia, Inc. (EYEN) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.